Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
MethodsX ; 12: 102507, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38204979

RESUMEN

This study aims to automatically analyze and extract abnormalities in the lung field due to Coronavirus Disease 2019 (COVID-19). Types of abnormalities that can be detected are Ground Glass Opacity (GGO) and consolidation. The proposed method can also identify the location of the abnormality in the lung field, that is, the central and peripheral lung area. The location and type of these abnormalities affect the severity and confidence level of a patient suffering from COVID-19. The detection results using the proposed method are compared with the results of manual detection by radiologists. From the experimental results, the proposed system can provide an average error of 0.059 for the severity score and 0.069 for the confidence level. This method has been implemented in a web-based application for general users.•A method to detect the appearance of viral pneumonia imaging features, namely Ground Glass Opacity (GGO) and consolidation on the chest Computed Tomography (CT) scan images.•This method can separate the lung field to the right lung and the left lung, and it also can identify the detected imaging feature's location in the central or peripheral of the lung field.•Severity level and confidence level of the patient's suffering are measured.

2.
J Biomed Phys Eng ; 12(6): 627-636, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36569571

RESUMEN

Background: Obstructive Sleep Apnea (OSA) is a respiratory disorder due to obstructive upper airway (mainly in the oropharynx) periodically during sleep. The common examination used to diagnose sleep disorders is Polysomnography (PSG). Diagnose with PSG feels uncomfortable for the patient because the patient's body is fitted with many sensors. Objective: This study aims to propose an OSA detection using the Fast Fourier Transform (FFT) statistics of electrocardiographic RR Interval (R interval from one peak to the peak of the pulse of the next pulse R) and machine learning algorithms. Material and Methods: In this case-control study, data were taken from the Massachusetts Institute of Technology at Beth Israel Hospital (MIT-BIH) based on the Apnea ECG database (RR Interval). The machine learning algorithms were Linear Discriminant Analysis (LDA), Artificial Neural Network (ANN), K-Nearest Neighbors (K-NN), and Support Vector Machine (SVM). Results: The OSA detection technique was designed and tested, and five features of the FFT were examined, namely mean (f1), Shannon entropy (f2), standard deviation (f3), median (f4), and geometric mean (f5). The OSA detection found the highest performance using ANN. Among the ANN types tested, the ANN with gradient descent backpropagation resulted in the best performance with accuracy, sensitivity, and specificity of 84.64%, 94.21%, and 64.03%, respectively. The lowest performance was found when LDA was applied. Conclusion: ANN with gradient-descent backpropagation performed higher than LDA, SVM, and KNN for OSA detection.

3.
J Biomed Phys Eng ; 11(5): 641-652, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34722409

RESUMEN

QT-interval prolongation is an important parameter for heart arrhythmia diagnosis. It is the time interval from QRS-onset to the T-end of electrocardiogram (ECG). Manual measurement of QT-interval, especially for 12-leads ECG, is time-consuming. Hence, an automatic QT-interval measurement is necessary. A new method for automatic QT-interval measurement is presented in this paper, which mainly consists of three parts, including QRS-complex detection, determination of QRS-onset, and T-end determination. The QRS-complex detection is based on the modified Pan-Tompkins algorithm. The T-end is defined based on Region of Interest (ROI) maximum limit. We compare and test our proposed QT-interval measurement method with reference measurement in term of correlation coefficient and range of 95% LoA. The correlation coefficient and the range of 95% LoA are 0.575 and 0.290, respectively. The proposed method is successfully implemented in ECG monitoring system using smartphone with high performance. The accuracy, positive predictive, and sensitivity of the QRS-complex detection in the system are 99.70%, 99.78%, and 99.92%, respectively. The range of 95% LoA for the comparison between manual and the system's QT-interval measurement is 0.216. The results show that the proposed method is dependable on the measure of the QT-interval and outperforms the other methods in term of correlation coefficient and range of 95% LoA.

4.
J Med Syst ; 31(2): 117-23, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17489504

RESUMEN

Chronic hepatitis C is a disease that is difficult to treat. At present, interferon might be the only drug, which can cure this kind of disease, but its efficacy is limited and patients face the risk of side effects and high expense, so doctors considering interferon must make a serious choice. The purpose of this study is to establish a simple model and use the clinical data to predict the interferon efficacy. This model is a combination of Feature Subset Selection and the Classifier using a Support Vector Machine (SVM). The study indicates that when five features have been selected, the identification by the SVM is as follows: the identification rate for the effective group is 85%, and the ineffective group 83%. Analysis of selected features show that HCV-RNA level, hepatobiopsy, HCV genotype, ALP and CHE are the most significant features. The results thus serve for the doctors' reference when they make decisions regarding interferon treatment.


Asunto(s)
Antivirales/uso terapéutico , Sistemas de Apoyo a Decisiones Clínicas/organización & administración , Hepatitis C Crónica/tratamiento farmacológico , Interferones/uso terapéutico , Adolescente , Adulto , Anciano , Biopsia , Femenino , Genotipo , Hepatitis C Crónica/sangre , Humanos , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , ARN/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA